Amazon.com, Inc. (NASDAQ:AMZN) is one of the best stocks to buy in 2026 according to billionaire George Soros. This tech stock is up around 25% over the past month. Amazon reported its Q1 2026 results on April 29, saying companywide revenue increased 17% YoY to $181.5 billion and net income rose 77% to $30.3 billion. […]
Amazon.com, Inc. (NASDAQ:AMZN) is one of the best stocks to buy in 2026 according to billionaire George Soros. This tech stock is up around 25% over the past month. Amazon reported its Q1 2026 results on April 29, saying companywide revenue increased 17% YoY to $181.5 billion and net income rose 77% to $30.3 billion. […]
La información financiera y operativa incluida en este comunicado de prensa está basada en estados contables intermedios consolidados condensados no auditados presentados en dólares estadounidenses (USD) y preparados de acuerdo con las Normas Internacionales de Información Financiera, según fueron emitidas por la Junta de Normas Internacionales de Contabilidad y adoptadas por la Unión Europea (Nor...
La información financiera y operativa incluida en este comunicado de prensa está basada en estados contables intermedios consolidados condensados no auditados presentados en dólares estadounidenses (USD) y preparados de acuerdo con las Normas Internacionales de Información Financiera, según fueron emitidas por la Junta de Normas Internacionales de Contabilidad y adoptadas por la Unión Europea (Normas de Contabilidad NIIF). Asimismo, este comunicado de prensa incluye medidas alternativas del rendimiento que no son NIIF, es decir, EBITDA, Flujo libre de efectivo, Efectivo/deuda neta y Días de capital de trabajo operativo. Para más información sobre estas medidas alternativas del rendimiento, ver el Anexo I.
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFR...
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free Cash Flow, Net cash / debt and Operating working capital days. See exhibit I for more details on these alternative performance measures.
mizoula MetLife ( MET ) Q1 earnings topped the Wall Street consensus, helped by 10% net investment income growth and its group benefits' favorable life underwriting and volume growth. Q1 adjusted EPS of $2.42, beating the average analyst estimate of $2.27, rose from $1.96 in last
mizoula MetLife ( MET ) Q1 earnings topped the Wall Street consensus, helped by 10% net investment income growth and its group benefits' favorable life underwriting and volume growth. Q1 adjusted EPS of $2.42, beating the average analyst estimate of $2.27, rose from $1.96 in last
Seeking Alpha More on Realty Income Realty Income: Improving Real Returns Realty Income: 3 New Reasons This Is Still A Hard Pass Realty Income: Still A Go-To REIT For Income Investors Realty Income Q1 earnings, revenue top consensus, but full-year guidance disappoints Realty Income FFO of $1.13 beats by $0.03, revenue of $1.55B beats by $160M
Seeking Alpha More on Realty Income Realty Income: Improving Real Returns Realty Income: 3 New Reasons This Is Still A Hard Pass Realty Income: Still A Go-To REIT For Income Investors Realty Income Q1 earnings, revenue top consensus, but full-year guidance disappoints Realty Income FFO of $1.13 beats by $0.03, revenue of $1.55B beats by $160M
Array Technologies press release ( ARRY ): Q1 Non-GAAP EPS of $0.06 beats by $0.11 . Revenue of $223.41M (-26.1% Y/Y) beats by $21.75M . Record total executed contracts and awarded orders at March 31, 2026 of $2.4 billion Achieved 2x book-to-bill with ~50% increase in
Array Technologies press release ( ARRY ): Q1 Non-GAAP EPS of $0.06 beats by $0.11 . Revenue of $223.41M (-26.1% Y/Y) beats by $21.75M . Record total executed contracts and awarded orders at March 31, 2026 of $2.4 billion Achieved 2x book-to-bill with ~50% increase in
TaskUs press release ( TASK ): Q1 Non-GAAP EPS of $0.35 beats by $0.01 . Revenue of $306.27M (+10.2% Y/Y) beats by $9.59M . Second Quarter and Full Year 2026 Outlook For the second quarter and full year 2026, TaskUs expects its financial results to Click to enlarge
TaskUs press release ( TASK ): Q1 Non-GAAP EPS of $0.35 beats by $0.01 . Revenue of $306.27M (+10.2% Y/Y) beats by $9.59M . Second Quarter and Full Year 2026 Outlook For the second quarter and full year 2026, TaskUs expects its financial results to Click to enlarge
MGE Energy ( NASDAQ: MGEE ) on Wednesday said it has commenced an underwritten public offering of $250 million of its common stock, subject to market conditions. The company said it expects to sell about $75 million of shares directly, while the remaining $175 million
MGE Energy ( NASDAQ: MGEE ) on Wednesday said it has commenced an underwritten public offering of $250 million of its common stock, subject to market conditions. The company said it expects to sell about $75 million of shares directly, while the remaining $175 million
simonkr/E+ via Getty Images CF Industries Holdings ( CF ) reported first-quarter results that exceeded Wall Street expectations, as strong global demand and constrained nitrogen supply boosted pricing across its core fertilizer products. Its shares rose 2.3% in extended trading Wednesday and are up 49% over the past 12
simonkr/E+ via Getty Images CF Industries Holdings ( CF ) reported first-quarter results that exceeded Wall Street expectations, as strong global demand and constrained nitrogen supply boosted pricing across its core fertilizer products. Its shares rose 2.3% in extended trading Wednesday and are up 49% over the past 12
Pattern Group Inc. press release ( PTRN ): Q1 GAAP EPS of $0.16 beats by $0.06 . Revenue of $774M (+43.3% Y/Y) beats by $58.14M . Adjusted EBITDA (non-GAAP) of $54 million, up 59% year over year. Net cash provided by operating activities for
Pattern Group Inc. press release ( PTRN ): Q1 GAAP EPS of $0.16 beats by $0.06 . Revenue of $774M (+43.3% Y/Y) beats by $58.14M . Adjusted EBITDA (non-GAAP) of $54 million, up 59% year over year. Net cash provided by operating activities for
Gold.com press release ( Gold ): Q3 GAAP EPS of $2.09. Revenue of $10.35B (+245.0% Y/Y). Revenues for the three months ended March 31, 2026 increased 244% to $10.351 billion from $3.009 billion for the three months ended March 31, 2025, and increased 60% from $6.477 billion for the three
Gold.com press release ( Gold ): Q3 GAAP EPS of $2.09. Revenue of $10.35B (+245.0% Y/Y). Revenues for the three months ended March 31, 2026 increased 244% to $10.351 billion from $3.009 billion for the three months ended March 31, 2025, and increased 60% from $6.477 billion for the three
BBB Foods press release ( TBBB ): Q1 Ps. 22,860 million EBITDA was Ps. 554 million in 1Q26, compared to Ps. 705 million in 1Q25. More on BBB Foods BBB Foods: Trade-Down Winner BBB Foods Inc. 2025 Q4 - Results - Earnings Call Presentation BBB Foods Inc. (TBBB) Q4 2025 Earnings Call Transcript BBB Foods outlines 29–32% revenue growth and up to 630 new stores in 2026 while accelerating store expansio...
BBB Foods press release ( TBBB ): Q1 Ps. 22,860 million EBITDA was Ps. 554 million in 1Q26, compared to Ps. 705 million in 1Q25. More on BBB Foods BBB Foods: Trade-Down Winner BBB Foods Inc. 2025 Q4 - Results - Earnings Call Presentation BBB Foods Inc. (TBBB) Q4 2025 Earnings Call Transcript BBB Foods outlines 29–32% revenue growth and up to 630 new stores in 2026 while accelerating store expansion BBB Foods reports Q4 results
Nurix Therapeutics (NASDAQ:NRIX) , a biotech innovator in targeted cancer therapies, reported a sale by its Chief Legal Officer amid strong one-year stock gains. Christine Ring, Chief Legal Officer of Nurix Therapeutics, reported the direct sale of 5,394 shares for a transaction value of ~$90,000 on May 1, 2026, per SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($16.76);...
Nurix Therapeutics (NASDAQ:NRIX) , a biotech innovator in targeted cancer therapies, reported a sale by its Chief Legal Officer amid strong one-year stock gains. Christine Ring, Chief Legal Officer of Nurix Therapeutics, reported the direct sale of 5,394 shares for a transaction value of ~$90,000 on May 1, 2026, per SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($16.76); post-transaction value based on May 1, 2026 market close ($16.81). Continue reading
Erik Isakson/DigitalVision via Getty Images Back in November of last year, I made the decision to downgrade shares of Comfort Systems USA, Inc. ( FIX ) from a Buy to a Hold. In the time that I had been bullish
Erik Isakson/DigitalVision via Getty Images Back in November of last year, I made the decision to downgrade shares of Comfort Systems USA, Inc. ( FIX ) from a Buy to a Hold. In the time that I had been bullish
MKS Instruments press release ( MKSI ): Q1 Non-GAAP EPS of $2.30 beats by $0.25 . Revenue of $1.08B (+15.4% Y/Y) beats by $30M . Second Quarter 2026 Guidance Revenue of $1,200 million, plus or minus $40 million Gross margin of 47.0%, plus or minus
MKS Instruments press release ( MKSI ): Q1 Non-GAAP EPS of $2.30 beats by $0.25 . Revenue of $1.08B (+15.4% Y/Y) beats by $30M . Second Quarter 2026 Guidance Revenue of $1,200 million, plus or minus $40 million Gross margin of 47.0%, plus or minus